Treatment guidelines for bladder cancer have changed significantly in recent years, due to the introduction of effective new drug combinations to treat the disease.
Greg Glasgow
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045
Research Bladder Cancer Clinical Trials
Treatment guidelines for bladder cancer have changed significantly in recent years, due to the introduction of effective new drug combinations to treat the disease.
Research that began at the University of Colorado Cancer Center may help doctors better treat patients with non-muscle invasive bladder cancer.
Community Prostate Cancer Bladder Cancer Kidney Cancer Testicular cancer
It’s one thing to develop cancer treatment guidelines in the U.S., where even the smallest health centers have access to the same basic technology for treatment and testing. But what about creating guidelines for oncologists in Sub-Saharan Africa, where access to medical resources can be limited and the disease can present differently?
Awareness Bladder Cancer Urology
In its early stages, bladder cancer can be easy to ignore or write off as something it isn’t – a UTI, a bladder infection, or other conditions that are commonly treated with an antibiotic.
The median age for receiving a bladder cancer diagnosis is 73, and a significant number of those living with the disease are in their 70s and 80s.
University of Colorado Cancer Center member Janet Kukreja, MD, assistant professor of urology in the University of Colorado School of Medicine, is taking part in this weekend’s Walk to End Bladder Cancer along with her office staff, fellow physicians, and even some of her patients. For this year’s “virtual” event, hosted by the Bladder Cancer Advocacy Network to kick off Bladder Cancer Awareness Month in May, participants walk in their own cities at their own pace, sharing their progress with others around the country.
Patient Care Bladder Cancer Cancer
“Have you ever had a dream when you wake up and everything is just kind of vibrating? It doesn’t make any sense but it kind of points the way?” asks Fort Collins artist and musician, Shelley Kerr.
University of Colorado Cancer Center led clinical trial data show that a predictive tool called COXEN may show which bladder cancer patients will respond to pre-surgical chemotherapy, a step towards allowing doctors to offer such chemotherapy to patients likely to respond, while moving more efficiently to other treatment options with patients unlikely to benefit. Results will be presented Monday, June 3 at 8:00am as oral abstract at the 2019 American Society for Clinical Oncology (ASCO) Annual Meeting (ASCO abstract #4506).
Gripped
March 27, 2024
Just 18 months after his leukemia diagnosis and on the brink of a bone marrow transplant, Chen defied the odds with an inspiring ascent. Reflecting on his journey, Chen's resilience shines through as he remains optimistic and determined for the future.
EurekAlert
March 06, 2024
Researchers at the University of Colorado Anschutz Medical Campus found that drugs like botox may slow head and neck cancer progression by targeting nerve interactions in tumor environments, impacting immune responses. This study could lead to new treatments for patients intolerant to traditional therapies.
Mile High Magazine
February 25, 2024
Christopher Lieu, MD speaks on March being Colorectal Cancer Awareness Month and the importance of screening.
National Institutes of Health (NIH)
February 21, 2024
In 2024, the network will launch a pilot study, known as the Vanguard Study on Multi-Cancer Detection, to address the feasibility of using multi-cancer detection (MCD) tests in future randomized controlled trials.